Modern combination antihypertensive pharmacotherapy
Mubarakshina O.A., Somova M.N., Batishcheva G.A.
Chronic obstructive pulmonary disease combined with arterial hypertension: efficacy and safety ofthesustained-release indapamide (Arifon® retard)
Ovcharenko S.I., Nersesyan Z.N., Morozova T.E.
Improving blood pressure control, organoprotection and metabolic disorders correction in patients with hypertension switching from diuretic-based combinations to fixed combination lisinopril + amlodipine + rosuvastatin
Nedogoda S.V., Chumachek E.V., Ledyaeva A.A., Tsoma V.V., Salasyuk A.S., Smirnova V.O., Khripaeva V.Y., Palashkin R.V., Popova E.A.
New trends in the treatment of hypertension in 2013: the renaissance of pulse pressure
Ostroumova O.D., Galeeva N.Y.
A new fixed combination of perindopril, indapamide and amlodipine. "Three in one" is the way to improve the results of arterial hypertension treatment
Temnikova E.A.
Use of diuretics in hypertensive patients with metabolic disturbances
Zhernakova Y.V., Chazova I.E.
Chronotherapy’s opportunities of a fixed combination of perindopril 10 mg/indapamide 2.5 mg in patients with a lack of night reduction in blood pressure
Aksenova A.V., Elfimova E.M., Litvin A.Y., Chazova I.E.
The place of Indapamide retard in the treatment of patients with left ventricular dysfunction and preserved systolic function in the presence of arterial hypertension
Tereshchenko S.N., Zhirov I.V.
Vascular stiffness in patients with arterial hypertension: possible antihypertensive therapy
Ostroumova O.D., Kochetkov A.I., Lopukhina M.V.
Antihypertensive efficacy of a fixed full-dose perindopril A-indapamide combination in patients with grades 2–3 arterial hypertension
Glukhova T.V., Solgalova S.A., Alferov V.V.
Efficacy and safety of different regimens of fixed combinationof perindopril 10 mg/indapamide 2.5 mg in patients with arterial hypertension
Elfimova E.M., Aksenova A.V., Litvin A.Y., Chazova I.E.
Arterial hypertension in the elderly and higher mental functions. Possibilities of an-tihypertensive therapy withArifon retard in the prevention of dementia.
Ostroumova O.D., Korsakova N.K., Varako N.A.
Perindopril - angiotensin-converting enzyme inhibitor is approved for usage
Napalkov D.A.
Final results of STRATEGYA Study (Russian Comparative Programme on a fixed,low-dose perindopril/indapamide combination efficacy in hypertensive patients with inadequateblood pressure control): use of a fixed, low- dose perindopril/indapamide combination in hypertensivepatients in real clinical practice
Martynyuk T.V., Kolos I.P., Chazova I.E., Martyniuk T.V., Kolos I.P., Chazova I.E.
Effectiveness and safety of indapamide sustained-release in the treatment of post partial hypertension
Gaisin I.R., Iskchakova A.S., Shilina L.V., Maksimov N.I., Vavilkina Z.V., Sava N.P.
1 - 15 of 15 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies